# Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus

> **NCT06495814** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fengmei Lian** · enrollment: 380 (estimated)

## Conditions studied

- Obese Impaired Glucose Tolerance
- Newly Diagnosed Obese Type 2 Diabetic Patients

## Interventions

- **DRUG:** 1/bag of Jinlida granules, 3 times/day, taken with hot water.

## Key facts

- **NCT ID:** NCT06495814
- **Lead sponsor:** Fengmei Lian
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06495814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06495814, "Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06495814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*